Document Type

Conference Proceeding

Publication Date

2022

Publication Title

American Journal of Respiratory and Critical Care Medicine

Abstract

Background Forced Vital Capacity (FVC) is a common parameter used to assess disease progression in patients with Interstitial lung disease (ILD) and acts as a surrogate for mortality. Previous studies suggest Functional Residual Capacity (FRC) may be an earlier predictor of disease progression in ILD. In this study, we compared ability of baseline FRC to FVC to predict one-year-mortality and respiratory related hospitalization in patients with mild to moderate ILD. Methods We retrospectively analyzed a prospective cohort of ILD patients attending a multidisciplinary ILD program from Jan 2017 to Oct 2021 at a large Health care system. Patients who had baseline pulmonary function tests were included and events were monitored for up to 12 months. Primary outcome: composite of all-cause mortality and hospitalization due to respiratory failure. Results A total of 323 patients with ILD were included. 23.21% (75) patients experienced composite outcome within 12 months. Outcome was common in older patients (70.5 vs 65.8, p<0.05). There was no difference in outcome between patients with IPF vs. Non-IPF and gender. Baseline FRC (2.52 L vs. 2.58 L) and FRC percentage predicted (84.2 vs. 84.1) was not statistically different between those who had composite outcome compared to those who did not. Whereas, both lower FVC (2.76 L vs. 2.44 L, difference 0.313,95% CI: 0.086, 0.539, p =0.006) and FVC PP (79.8 vs. 72.1, difference 7.79, 95% CI: 2.66, 12.91, p=0.003) were significant predictors of one year mortality or/and respiratory related hospitalization. In the multivariate logistic regression analysis, FVCPP was statistically significant for disease progression after adjusting for age, gender, and diagnosis of IPF (adjusted odds ratio 0.98; 95% CI: 0.96-0.99). Conclusion In this cohort of patients with mild to moderate ILD, FRC at baseline was not a reliable predictor of one-year respiratory related hospitalization or mortality. However, both FVC and FVCPP are reliable markers even after adjusting for age, gender, and diagnosis of IPF.

Volume

205

Issue

Meeting Abstracts

First Page

A4715

Comments

C70 NEW STUDIES OFLUNGFIBROSIS / Thematic Poster Session / Tuesday, May 17/09:30 AM-03:45 PM / Area K, Hall F (North Building, Exhibition Level), Moscone Center

Last Page

A4715

Share

COinS